Jan Astermark
111 – 120 of 191
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Influence of the pre-analytical specimen storage conditions on thrombin generation assay
(2010) XXIXth International Congress of the World Federation of Hemophilia In Haemophilia 16(Suppl. 4). p.45-45
- Contribution to journal › Published meeting abstract
-
Mark
F8 haplotype and recombinant product use in the Hemophilia Inhibitor Genetics Study (HIGS)
- Contribution to journal › Published meeting abstract
-
Mark
Inhibitor development: patient-determined risk factors.
- Contribution to journal › Article
-
Mark
Combination of FVIII and by-passing agent potentiates in vitro thrombin production in haemophilia A inhibitor plasma.
- Contribution to journal › Article
-
Mark
Von Willebrands sjukdom--från biokemi till klinisk praxis.
- Contribution to journal › Scientific review
-
Mark
Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report.
- Contribution to journal › Article
-
Mark
Physical activity for prevention of osteoporosis in patients with severe haemophilia on long-term prophylaxis.
- Contribution to journal › Article
-
Mark
Thrombin generation in vitro in the presence of by-passing agents in siblings with severe haemophilia A.
- Contribution to journal › Article
-
Mark
Clinical issues in inhibitors
- Contribution to journal › Scientific review
- 2009
-
Mark
Thrombin generation assay: a useful routine check-up tool in the management of patients with haemophilia?
- Contribution to journal › Article